Concepedia

Publication | Open Access

Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial

DOIFull Paper Access

135

Citations

29

References

2020

Year

Rory J. McCrimmon, Andrei‐Mircea Catarig, Juan P. Frías, Nanna L. Lausvig, Carel W. le Roux, Desirée Thielke, Ildiko Lingvay
Diabetologia

Abstract

This trial was supported by Novo Nordisk A/S, Denmark.

References

YearCitations

Page 1